Molecular Heterogeneity, Standardized Assessment, and Therapeutic Advances of HER2 in Urothelial Carcinoma

Advances in Clinical Medicine 2026

View at publisher

Authors: 方赫窦

DOI: 10.12677/acm.2026.163870

Cited by: 0

References: 11

Fields of Study & Subjects

Bladder and Urothelial Cancer Treatments HER2/EGFR in Cancer Research Lung Cancer Treatments and Mutations

References 11